Comorbidity in chronic obstructive pulmonary disease

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

CC Chemokine Receptor 5 and CXC Chemokine Receptor 6 Expression by Lung CD8+ Cells Correlates with Chronic Obstructive Pulmonary Disease Severity Christine.
S.R Salpeter, T.M Ormiston, E.E Salpeter, P.J Poole, C.J Cates 
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort  Rupert C M Jones,
Mapping the COPD Assessment Test onto EQ-5D
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Aspirin Use Among U.S. Adults
Nationwide survey on the 2005 Guidelines for the Management of Community-Acquired Adult Pneumonia: Validation of differentiation between bacterial pneumonia.
Simple versus complex COPD: implications for health-care management
David B. Price, MBBChir, MA, FRCGP, Barbara P
Advancing Palliative Care as a Human Right
Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Experience of Advanced Chronic Obstructive Pulmonary Disease: Metasynthesis of Qualitative Research  Rebecca T. Disler, MSc, PDAN, BSc, BN, RN, Anna Green,
Shireen Mirza, MBBS, Roberto Benzo, MD  Mayo Clinic Proceedings 
Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure  Jacques D. Donzé, MD, MSc, Patrick.
Musculoskeletal Comorbidities in Cardiac Patients: Prevalence, Predictors, and Health Services Utilization  Susan Marzolini, MSc, Paul I. Oh, MD, David.
Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease  Nina Raju, MD, MsC, Magdalena Sobieraj-Teague, MBBS, Jack Hirsh, MD,
Inspiratory Muscle Training for Patients With Chronic Obstructive Pulmonary Disease: A Practical Guide for Clinicians  Kylie Hill, PhD, Nola M. Cecins,
Exercise Frequency, Health Risk Factors, and Diseases of the Elderly
From the Feds: Research, programs, and products
Personalized Disease Models on a Chip
Prevalence of true-positive, false-negative and false-positive cases of chronic obstructive pulmonary disease identified with the fixed-limit Global Initiative.
Estimating Maximum Work Rate During Incremental Cycle Ergometry Testing From Six- Minute Walk Distance in Patients With Chronic Obstructive Pulmonary Disease 
K-Means Cluster Analysis of Rehabilitation Service Users in the Home Health Care System of Ontario: Examining the Heterogeneity of a Complex Geriatric.
Value in Health Regional Issues
Vector control: a cornerstone in the malaria elimination campaign
Michael L. Bailey, MBBS, Sven M. Richter, MD, Daniel V
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
The Experience of Cancer-Related Fatigue and Chronic Fatigue Syndrome: A Qualitative and Comparative Study  Barbara Bennett, RN, BSc, PhD, David Goldstein,
Tobacco smoke as a risk factor for allergic sensitization in adults: Conclusions of a systematic review and meta-analysis  Beatriz Mónico, MSc, Jorge.
Cognitive impairments in the locked-in syndrome: A case report
Intrapleural Instillation of Autologous Blood for Persistent Air Leak in Spontaneous Pneumothorax in Patients With Advanced Chronic Obstructive Pulmonary.
Meta-analysis of the Effect of a Pulmonary Rehabilitation Program on Respiratory Muscle Strength in Patients with Chronic Obstructive Pulmonary Disease 
Volume 97, Issue 1, Pages (January 1990)
Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology.
Personalized Disease Models on a Chip
Maximal Cardiorespiratory Fitness Testing in Individuals With Chronic Stroke With Cognitive Impairment: Practice Test Effects and Test-Retest Reliability 
Risk factors and indications for readmission after lower extremity amputation in the American College of Surgeons National Surgical Quality Improvement.
Volume 58, Issue 6, Pages (June 2015)
Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral?  Elliot Wakeam, MD, MPH, Joseph.
The impact of smoking in primary spontaneous pneumothorax
The Trajectory of Dyspnea in Hospitalized Patients
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort  Rupert C M Jones,
Musculoskeletal Comorbidities in Cardiac Patients: Prevalence, Predictors, and Health Services Utilization  Susan Marzolini, MSc, Paul I. Oh, MD, David.
Protein-losing enteropathy
Volume 17, Issue 2, Pages (February 1950)
Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass  Benjamin Medalion, MD, Michael G. Katz, MD,
Diagnosing pancreatic malignancy in the setting of chronic pancreatitis: is there room for improvement?  James J. Farrell, MD  Gastrointestinal Endoscopy 
Effects of Mobilization and Tactile Stimulation on Chronic Upper-Limb Sensorimotor Dysfunction After Stroke  Jacqueline M. Winter, PhD, Peter Crome, DSc,
Society for Investigative Dermatology 2010 Meeting Minutes
Severe Asthma Global Evaluation (SAGE): An Electronic Platform for Severe Asthma  Eve Denton, MBBS (Hons), MPH, FRACP, Fiona Hore-Lacy, BNutSci (Hons),
Effect of carbohydrate supplementation on walking performance in peripheral arterial disease: A preliminary physiologic study  Glenn A. Barker, PhD, Simon.
AGA technical review on osteoporosis in gastrointestinal diseases
Β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals  Anne Orholm Nielsen, Lars.
Organization news Archives of Physical Medicine and Rehabilitation
The global challenge of chronic kidney disease
Taking UP the chronic pulmonary obstructive disease gauntlet
Systematic review of the impact of osteoarthritis on health outcomes for comorbid disease in older people  L. Parkinson, D.L. Waters, L. Franck  Osteoarthritis.
Metabolic Syndrome in South Korean Patients with Chronic Obstructive Pulmonary Disease: A Focus on Gender Differences  Jinhee Kim, Jae Yong Yoo, Hee Sun.
The hypothesis that abnormal BH4 metabolism impairs kidney function
A Systematic Review of the Outcomes of Cardiovascular Exercise Programs for People With Down Syndrome  Karen J. Dodd, PhD, Nora Shields, PhD  Archives.
Lung Cancer in New Zealand: Patterns of Secondary Care and Implications for Survival  Wendy Stevens, MBBS, Graham Stevens, MD, FRANZCR, John Kolbe, MBBS,
A comparison between descending phlebography and duplex Doppler investigation in the evaluation of reflux in chronic venous insufficiency: A challenge.
Rupal Shroff, B. S. , Craig H. Syrop, M. D. , William Davis, M. D
Impact of antibiotic restrictions: the patient's perspective
Inspiratory Muscle Training for Patients With Chronic Obstructive Pulmonary Disease: A Practical Guide for Clinicians  Kylie Hill, PhD, Nola M. Cecins,
Popliteal entrapment syndrome: A report of tibial nerve entrapment
Definitions of primary graft dysfunction after lung transplantation: Differences between bilateral and single lung transplantation  Takahiro Oto, MD,
Volume 3, Issue 5, Pages (November 2017)
Presentation transcript:

Comorbidity in chronic obstructive pulmonary disease Netsanet A. Negewo, B Pharm, MSc, Vanessa M. McDonald, DipHlthScien (Nurs), BNurs, PhD (Medicine), Peter G. Gibson, MBBS, FRACP  Respiratory Investigation  Volume 53, Issue 6, Pages 249-258 (November 2015) DOI: 10.1016/j.resinv.2015.02.004 Copyright © 2015 The Japanese Respiratory Society Terms and Conditions

Fig. 1 Comorbidities associated with COPD and their prevalence. The prevalence for cardiovascular diseases was taken from Refs. [26,27]; metabolic syndrome, Refs. [25,26]; osteoporosis, Ref. [52]; skeletal muscle dysfunction, Ref. [57]; psychiatric diseases, Refs. [83,84]; cognitive impairment, Ref. [91]; gastrointestinal diseases, Refs. [75,30]; and for respiratory diseases, Refs. [63,64,68,71,30]. Respiratory Investigation 2015 53, 249-258DOI: (10.1016/j.resinv.2015.02.004) Copyright © 2015 The Japanese Respiratory Society Terms and Conditions